This new serum is the ‘next frontier in cellular skin rejuvenation,’ according to an expert
Medik8 has launched a new serum that combines PDRN and exosomes for skin rejuvenation. The Exo-PDRN Primastic+ Youthful Vitality Serum aims to improve skin radiance, tone, and vitality while being gentle enough for post-procedure use. Experts believe this serum represents a significant advancement in cellular skin rejuvenation technology.
- ▪The Exo-PDRN Primastic+ Serum targets multiple signs of aging.
- ▪It uses clinically-backed ingredients like a proprietary exosome complex and a vegan version of PDRN.
- ▪The serum has received nearly 1,200 reviews on the Medik8 website, with many users reporting visible improvements in their skin.
New York Post files mainly under news. We currently carry 10,965 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Page Six |
| Canonical URL | https://pagesix.com/2026/06/06/style/medik8-new-pdrn-and-exosome-serum-is-doctor-approved/ |
| Publication time | Sat, 06 Jun 2026 11:04:33 -0400 |
| Retrieval time | 2026-06-06T15:06:21.161Z |
| Last seen | 2026-06-06T15:51:19.525Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | G2wJr5c6cKsx |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Shopping This new serum is the ‘next frontier in cellular skin rejuvenation,’ according to an expert By Erica Radol Published June 6, 2026, 11:04 a.m. ET Celebrities and Hollywood facialists are fans of Medik8, and the British brand's latest launch combines the powers of PDRN and exosomes. Medik8 See more of our coverage in your search results. Add Page Six on Google Page Six may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. The fountain of youth might not be real, but the science behind Medik8‘s latest skin care launch is.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Page Six.
Discussion
0 commentsMore from Page Six
